外科医生年度与累计手术量预测脑肿瘤切除术后早期结局
作者认为应考虑神经肿瘤外科亚专业化。
要点
- 高累计/高年度手术量医生组患者中位住院5天,低于其他三组的8、8、6天。
- 高累计/高年度手术量医生组患者非常规出院率41%,低于其他三组的48%、50.9%、43.9%。
- 高累计/高年度手术量医生组患者30天死亡率3.3%,低于低累计/低年度组的5.4%和低累计/高年度组的5.2%。
核心结论
- 有一定证据表明由高累计和高年度手术量外科医生手术可改善术后结局,提示应考虑神经肿瘤外科亚专业化。
研究设计与样本
- 基于纽约州规划与研究合作系统(SPARCS)的人群队列研究,纳入2005年至2014年间接受脑肿瘤切除术的患者n=10,258例,按外科医生累计和年度手术量分组。
主要发现
- 高累计/高年度组患者中位住院5天,低累计/低年度组8天,低累计/高年度组8天,高累计/低年度组6天(P<0.01)。
- 高累计/高年度组患者中位费用70,025美元,低累计/低年度组77,043美元,低累计/高年度组93,715美元,高累计/低年度组77,018美元(P<0.01)。
- 高累计/高年度组非常规出院率41%,低累计/低年度组48%,低累计/高年度组50.9%,高累计/低年度组43.9%(P<0.01)。
- 高累计/高年度组脑积水率9.9%,低累计/低年度组10.4%,低累计/高年度组13.7%(P=0.02)。
- 高累计/高年度组内科并发症6.9%,低累计/低年度组11.2%,低累计/高年度组11.5%(P<0.01);神经并发症44.1% vs 46.8% vs 48.1%(P=0.03);30天再手术5.1% vs 6.9% vs 7.1%(P<0.01);30天死亡3.3% vs 5.4% vs 5.2%(P<0.01)。
临床怎么用
- 作者认为,由高累计和高年度手术量外科医生手术可能改善术后结局,应考虑神经肿瘤外科亚专业化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgeon volume has been previously shown to affect patient outcomes. However, data related to neuro-oncologic surgery are limited and do not include neurologic morbidities as an outcomes measure. In this study, we aimed to determine if 5-year surgeon cumulative and annual volumes predict early postoperative outcomes in patients after brain tumor surgery. METHODS: A population-based cohort of patients (n = 10,258) undergoing brain tumor resection between 2005 and 2014 were included for study using the New York Statewide Planning and Research Cooperation System. Surgeons were categorized by their cumulative and annual surgical volume. RESULTS: Patients treated by high cumulative/high annual (HC/HA) volume surgeons had shorter length of stay (median, 5 days vs. 8 days vs. 8 days vs. 6 days, respectively; P < 0.01), lower charges (median, 70,025 vs. $77,043 vs. $93,715 vs. $77,018 respectively; P < 0.01) and less nonroutine discharge (41% vs. 48% vs. 50.9% vs. 43.9% respectively; P < 0.01) compared with patients treated by surgeons from the low cumulative/low annual (LC/LA), LC/HA, HC/LA groups. Similarly, HC/HA volume surgeons also had lower rate of hydrocephalus (9.9% vs. 10.4% vs. 13.7% respectively; P = 0.02), medical complications (6.9% vs. 11.2% vs. 11.5% respectively; P < 0.01), neurologic complications (44.1% vs. 46.8% vs. 48.1% respectively; P = 0.03), 30-day reoperation (5.1% vs. 6.9% vs. 7.1% respectively; P < 0.01) and 30-day death (3.3% vs. 5.4% vs. 5.2%; P < 0.01) compared with LC/LA and LC/HA volume surgeons. CONCLUSIONS: There is some evidence for improved postoperative outcomes when surgery is performed by HC and HA volume surgeons. This finding suggests that subspecialization in surgical neuro-oncology should be considered.
引用
- Ramakrishna R, Hsu WC, Mao J, et al. Surgeon Annual and Cumulative Volumes Predict Early Postoperative Outcomes After Brain Tumor Resection. World Neurosurg. 2018. PMID: 29524715. doi:10.1016/j.wneu.2018.02.172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。